A silent disorder is rising among older people worldwide, as millions unknowingly grapple with glaucoma – an eye condition that can cause irreversible blindness but shows no obvious symptoms until late-stage disease, ophthalmologists warn.
It’s predicted that by 2050, the number of people with glaucoma will surge by more than 200%, highlighting an urgent need for heightened awareness, early detection, and advanced treatment strategies.
“That’s a lot of people with a blinding disease who don’t know they have it,” said Joel S. Schuman, MD, a professor of ophthalmology and co-director of the Glaucoma Service at Wills Eye Hospital in Philadelphia. “Late in the disease, people may notice they’re tripping over the curb, or walking into things they didn’t see. It really is only in very advanced disease that people notice there’s anything wrong.”
Glaucoma is the second leading cause of blindness worldwide, affecting 3 million people in the United States, and yet half of those affected are unaware, according to the CDC.
Recent research at the University of Gothenburg in Sweden underscores glaucoma’s stealthy nature: 5% of 560 70-year-olds had the disease, and half of those did not know they had it before they took part in the study.
“Living with glaucoma, especially without realizing it, can be very isolating,” said Lena Havstam Johansson, a PhD student at the University of Gothenburg and a specialist nurse at Sahlgrenska University Hospital, who did the study. “It may lead people to stay at home to avoid the trouble.”
Once symptoms arise, some may notice patchy blind spots in their peripheral vision, and in their central vision in late stages.
While many people assume they are getting clumsier with age, Schuman said, they often have a condition that can be slowed with the right treatment.
Glaucoma occurs when there is increased pressure within the eye, causing damage to the optic nerve, which transmits information from the eye to the brain. If left untreated, it will result in partial vision loss or complete blindness. It often develops gradually and without noticeable symptoms in its early stages, earning it the nickname “the silent thief of sight.”
Though there are various types of the disease, about nine in 10 people in the U.S. have primary open-angle glaucoma (POAG).
It is most common among people over the age of 60, those with a family history of glaucoma, and people who have diabetes. It disproportionately affects Black people, who are six times more likely than White people to have advanced vision loss from the disease.
More than 120,000 people in the U.S. are blind from glaucoma, accounting for 9% to 12% of all cases of blindness.
Glaucoma treatments range from eyedrops to laser treatments to surgery, all of which aim to reduce eye pressure. Some doctors will recommend oral medication along with eyedrops.
“We have a lot of treatment options, and they work pretty well,” Schuman said. “But the first step is the person knowing they have glaucoma, and the second step is that person seeking care.
Rarer types of glaucoma include normal-tension glaucoma, which is more common among people of Japanese ancestry, and congenital glaucoma, which is present from birth and affects about one in 10,000 babies born in the U.S.
The best way to ensure early detection and treatment is to get regular eye exams – every 2 to 4 years for adults under the age of 55, and annually thereafter, said Annie Wu, MD, a clinical assistant professor of ophthalmology at the Kellogg Eye Center at the University of Michigan.
The fact that glaucoma’s symptoms are slow to develop, coupled with a lack of access to eye specialists many Americans face, make the disease even more dangerous.
The University of Pennsylvania is among those trying to change that. The Philadelphia school has hosted free glaucoma screening programs for Black residents. Black Americans are five to six times more likely to be diagnosed with glaucoma, the school said.
There are a number of organizations that also offer access to free glaucoma screening.
Glaucoma testing can be done during a regular eye exam and may involve one test or a combination of tests that are relatively quick and painless. Those include dilating the pupil with eyedrops to examine the optic nerve, along with measuring thickness of the cornea to find out your risk for the disease, which is higher if the cornea is thin.
“It is important not to wait until you have symptoms – if glaucoma is getting so bad you’re starting to notice it in your central vision, it means you’ve lost pretty much all of your peripheral field,” Wu said. “Definitely go see an eye doctor, no matter what your family history is.”
Sources
American Journal of Ophthalmology: “The Changing Face of Primary Open-Angle Glaucoma in the United States: Demographic and Geographic Changes from 2011-2050.”
Acta Ophthalmologica: “The prevalence of glaucoma in a 70-year-old Swedish population in the city area of Gothenburg.”
Joel S. Schuman, MD, professor of ophthalmology, co-director, Glaucoma Service, Wills Eye Hospital, Philadelphia.
Lena Havstam Johansson, PhD student, University of Gothenburg; specialist nurse, Sahlgrenska University Hospital, Gothenburg, Sweden.
Annie Wu, MD, clinical assistant professor of ophthalmology, Kellogg Eye Center, University of Michigan, Ann Arbor.
Penn Medicine: “Glaucoma Awareness Campaign Provides Free Screenings to Black Individuals in Philadelphia.”
